Yoshikazu Koike
Kurashiki, 7010192, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Peripheral Blood T-Cell Receptor Repertoire and Host Immune Background in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Journal: Acta medica Okayama
Published: June 30, 2026
Overlap syndrome between sarcoidosis and Sjögren's disease presenting as hypopituitarism: case report and review of literature.
Journal: Endocrine journal
Published: May 10, 2026
Efficacy of adjuvant chemotherapy for triple-negative early breast cancer with tumor size ≤ 1 cm and node-negative from the National Clinical Database-Breast Cancer Registry in Japan.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 06, 2026
Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapy.
Journal: Breast cancer (Tokyo, Japan)
Published: December 17, 2024
Alcohol consumption and breast cancer prognosis after breast cancer diagnosis: a systematic review and meta‑analysis of the Japanese Breast Cancer Society Clinical Practice Guideline, 2022 edition.
Journal: Breast cancer (Tokyo, Japan)
Published: March 02, 2023
Neoadjuvant Epirubicin-Cyclophosphamide Therapy followed by Nab-Paclitaxel in Patients with Operable Breast Cancer-A Single-Center Phase Ⅱ Trial
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 08, 2022
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
Journal: Breast cancer (Tokyo, Japan)
Published: May 19, 2020
Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
Journal: Breast cancer (Tokyo, Japan)
Published: September 28, 2019
CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.
Journal: BMC cancer
Published: June 06, 2018
Comprehensive immunohistochemical analyses on expression levels of hedgehog signaling molecules in breast cancers.
Journal: Breast cancer (Tokyo, Japan)
Published: April 05, 2018
Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Journal: Breast cancer (Tokyo, Japan)
Published: September 23, 2016
Last Updated: 09/26/2026